Add Yahoo as a preferred source to see more of our stories on Google. Commonly known as atopic dermatitis, eczema is "the itch that rashes," says Dr. Shi, meaning that an itching sensation often ...

When dealing with a dry, flaky, or itchy scalp, finding the best shampoos for psoriasis can sometimes be difficult. Psoriasis, one of the most common skin conditions in the United States, affects ...

How does a doctor tell the difference between scalp psoriasis and seborrheic dermatitis of the scalp? Your doctor can usually tell whether you have scalp psoriasis, seborrheic dermatitis or both based ...

Psoriasis and seborrheic dermatitis are often viewed as overlapping conditions, but a recent investigation found no clear connection between the diseases. The systematic review and network ...

In a cross-sectional study published in the Medicina Journal, researchers from Montenegro and Serbia compared the hematological parameters and serum biomarkers of inflammation and immunity in patients ...

Inflammatory skin diseases are often diagnosed by "first impression" and can be easily misdiagnosed. A new smartphone app using artificial intelligence (AI) may be able to assist with the diagnosis of ...

A deep learning (DL) model based on dermatoscopic images can differentiate scalp psoriasis from seborrheic dermatitis, according to a study recently published in Frontiers in Medicine. Zhang Yu, from ...

Patients with atopic dermatitis (AD) who took dupilumab had a higher risk of developing psoriasis compared with those receiving other agents. Results from the large population-based retrospective ...

Researchers investigated whether responses to questionnaires on psoriasis and atopic dermatitis prevalence remained consistent over time. When asked about a history of atopic dermatitis, cohort study ...

- Dermavant recently filed an sNDA in the U.S for the treatment of atopic dermatitis in adults and children two years of age and older, with a PDUFA date in Q4 2024 - LONG BEACH, Calif. & BASEL, ...

Treating atopic dermatitis (AD) with dupilumab vs other systemic agents increased the risk of developing psoriasis over 3 years, a cohort study found. Addressing postmarketing reports of psoriasis in ...